COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
BackgroundCancer has been suggested as a risk factor for severe outcome of SARS-CoV-2 infection. In this population-based study we aimed to identify factors associated with higher risk of COVID-19 and adverse outcome.MethodsData on all confirmed SARS-CoV-2 positive patients in the period January 1 t...
Main Authors: | Tom Børge Johannesen, Sigbjørn Smeland, Stein Aaserud, Eirik Alnes Buanes, Anna Skog, Giske Ursin, Åslaug Helland |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.652535/full |
Similar Items
-
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 – merging clinical research and standard healthcare
by: Elisa Bjørgo, et al.
Published: (2024-06-01) -
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
by: Siri Børø, et al.
Published: (2022-11-01) -
A nationwide, prospective collection of patient reported outcomes in the Cancer Registry of Norway
by: Ylva Maria Gjelsvik, et al.
Published: (2022-10-01) -
Kreftregisteret – full fart fremover. Utviklingen de siste 10 år.
by: Giske Ursin
Published: (2022-10-01) -
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
by: Christian Wilhelm Langberg, et al.
Published: (2023-07-01)